Apr 8, 2026
How AI Is Compressing the Decade-Long R&D Timeline
A drug that fails in Phase III trials has consumed $500M–$1B. AI identifies the same failure at the hypothesis stage, when total spend is under $100K. Nearly 40% of executives now rank R&D as the top function benefiting from AI investment.
S
Sobin George Thomas